NIH Funding Opportunities (Notices, PA, RFA)

Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 2 hours 54 min ago
BRAIN Initiative: Brain-Behavior Quantification and Synchronization Transformative and Integrative Models of Behavior at the Organismal Level (U01 Clinical Trial Optional)
Funding Opportunity RFA-DA-24-040 from the NIH Guide for Grants and Contracts. This Brain-Behavior Quantification and Synchronization notice of funding opportunity (NOFO) seeks applications that bring together transdisciplinary teams and aim to 1) develop, validate, and apply cutting-edge tools and methods for minimally invasive, multi-dimensional, high-resolution objective measurement of behavior at the organismal level, with synchronous capture of dynamic environmental data; 2) develop advanced analytic approaches to integrate multidimensional behavioral, neural and environmental data; and 3) develop and test new theoretical and computational models aiming to advance understanding of behavior as a complex dynamic system. Proposed projects are expected to be designed with the capacity to integrate synchronously recorded neural data and/or inform existing models of neurobehavioral function, such as those developed with the support of the NIH BRAIN Initiative. This BRAIN Initiative NOFO is specifically soliciting applications proposing basic research involving human subjects aiming to reveal and understand fundamental principles underlying behavioral function, including research limited to observational studies or analysis of human data. Applications proposing research using exclusively non-human animal models should apply under the companion NOFO, RFA-DA-24-041. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP).
Categories: Job Watch, Literature Watch
Notice of Correction to Budget Instructions for PAR-24-164, Developmental AIDS Research Center on Mental Health and HIV/AIDS and PAR-24-165, AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
Notice NOT-MH-24-335 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change to PAR-23-061 and PAR-23-062, Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R01/R21 Clinical Trial Optional)
Notice NOT-MH-24-321 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of change to PAR-23-060, Formative and Pilot Intervention Research to Optimize HIV Prevention and Care Continuum Outcomes (R34 Clinical Trial Optional)
Notice NOT-MH-24-320 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Extension of the Expiration Date for PAR-21-282, "Blueprint Medtech: Small Business Translator (U44 Clinical Trial Optional)"
Notice NOT-DA-24-027 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of NCCIH Participation in Notice of Special Interest (NOSI): Climate Change and Health"
Notice NOT-AT-24-044 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Update to HeLa Cell Whole Genome Sequence Data Submission and Access Under the NIH Lacks-Family Agreement
Notice NOT-OD-24-098 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): Administrative Supplement for Natural History and Longitudinal Dynamics of Lung Nodules using the NLST dataset
Notice NOT-CA-24-058 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Funding Opportunity PAR-24-208 from the NIH Guide for Grants and Contracts. NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): Interpersonal Communication Research to Advance Dental, Oral, and Craniofacial Health over the Lifecourse
Notice NOT-DE-24-027 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
NIH HEAL Initiative: Coordinated Approaches to Pain Care in Health Care Systems (UG3/UH3 - Clinical Trial Optional)
Funding Opportunity RFA-NS-24-041 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement solicits research applications that propose implementation science methodology to embed existing evidence-based coordinated pain care models into a variety of public and private health care systems (HCS) where this type of care does not exist. Applications that combine comparative effectiveness studies of innovative coordinated care models with strong implementation science methodology to embed effective approaches into HCSs also are encouraged. This NOFO requires that the coordinated care model under study be embedded into the health care delivery system of the applicant institutions. Coordinated pain care approaches proposed for study should include interventions from multiple disciplines as described below and should aim to improve pain management based on the biopsychosocial model of pain. Emphasis should be on populations of patients with greatest need. This NOFO solicits applications from HCS who have resources and infrastructure to support research and implementation of study approaches in partnership with those HCS who lack research resources or experience and would benefit most from implementation of cost-effective coordinated pain care. HCS partners who serve populations that are under-represented in research are encouraged to apply. Models of coordinated care proposed by the study team should be aligned with health care resources of the participating HCS and should be informed through engagement of stakeholders including patients, providers, healthcare system executives, policy makers, and payors. The study teams must include health care providers from multiple disciplines and implementation scientists.
Categories: Job Watch, Literature Watch
Notice of Correction to Application Form Instructions for PAR-24-086 "Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)"
Notice NOT-AT-24-045 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Participation of the National Cancer Institute (NCI) in NOT-HL-24-014, Request for Information (RFI): Critical Challenges and Opportunities For Lymphatic Scientific, Clinical, and Disease Communities
Notice NOT-CA-24-057 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Addressing Health Inequities in Clinical Diagnostics (R41/R42 and R43/R44 Clinical Trials Not Allowed): Notice of Technical Webinar
Notice NOT-TR-24-026 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Childcare Costs for Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellows and Institutional Research Training Awards
Notice NOT-OD-24-116 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Single Source: NINDS Exploratory Clinical Trials (U01 Clinical Trial Required)
Funding Opportunity PAR-24-215 from the NIH Guide for Grants and Contracts. This is a non-competitive funding opportunity intended to fund a single award. The National Institute of Neurological Disorders and Stroke is announcing its intent to issue a single source cooperative agreementto the Hennepin Healthcare Research Institute to submit a renewal application to complete the phase II Hyperbaric Oxygen Brain Injury Treatment (HOBIT) clinical trial.
Categories: Job Watch, Literature Watch
Request for Information: Soliciting Input on Opportunities, Gaps, and Challenges in Global Health Research in Neurological Diseases and Stroke
Notice NOT-NS-24-018 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Request for Information (RFI): Critical Challenges and Opportunities For Lymphatic Scientific, Clinical, and Disease Communities
Notice NOT-HL-24-014 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Safety and Efficacy of Amyloid-Beta Directed Antibody Therapy in Mild Cognitive Impairment and Dementia with Evidence of Lewy Body Dementia and Amyloid-Beta Pathology (U01 - Clinical Trial Required)
Funding Opportunity RFA-NS-25-010 from the NIH Guide for Grants and Contracts. This RFA is soliciting applications proposing placebo-controlled, clinical trials to determine the efficacy and safety of FDA approved monoclonal antibody therapies directed against amyloid compared to placebo in diverse "mixed dementia" populations with a focus on Lewy Body Dementias (LBD). In this NOFO the mixed-etiology dementias (MED) that are of interest and that are in scope are cognitive impairment and dementia cases positive for 1) canonical Alzheimers pathology biomarkers (for example, amyloid deposition assessed using positron emission tomography and/or low cerebrospinal fluid amyloid beta 42 combined with elevated phosphorylated tau; and 2) a clinical LBD diagnosis, i.e. Parkinsons disease dementia (PDD) and/or dementia with Lewy bodies (DLB). Bayesian approaches with response adaptive randomization to examine specific subgroups are encouraged. Successful applications will be powered to determine efficacy in diverse populations representative of the distribution of the disease in the United States by sex, race/ethnicity, and geographic distribution. Applications must include elements of patient and community engagement that are incorporated into all stages of program development and at all levels of the organizational structure.
Categories: Job Watch, Literature Watch
SBIR E-Learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed)
Funding Opportunity RFA-ES-24-003 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to further the development of Technology-Enhanced Training Products for the health and safety training of hazardous materials (HAZMAT) workers; waste treatment personnel; skilled support personnel associated with an emergency/disaster; emergency responders in biological hazard response, infectious disease response, and medical waste cleanup; emergency responders in disasters; and worker resiliency training. Technology-enhanced training products as defined by the Worker Training Program (WTP) include, but are not limited to, supporting training through various venues such as online training, mobile device training, virtual reality, and serious gaming. These advanced technologies complement all phases of training that can enhance, supplement, improve, and provide health and safety training for hazardous materials workers. These products must complement the goals and objectives of the WTP. The major objective of the NIEHS WTP is to prevent work related harm by training workers in how best to protect themselves and their communities from exposure to hazardous materials. The financial support for this initiative comes directly from NIEHS Worker Education and Training Branch SBIR funds.
Categories: Job Watch, Literature Watch